BiotechTube

NKTR-181 BID tablets

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
72
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Low Back Pain

Conditions

Low Back Pain, Chronic Pain

Trial Timeline

Apr 14, 2015 โ†’ Jan 1, 2018

NCT ID
NCT02367820

About NKTR-181 BID tablets

NKTR-181 BID tablets is a phase 3 stage product being developed by Nektar Therapeutics for Low Back Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02367820. Target conditions include Low Back Pain, Chronic Pain.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02367820Phase 3Completed

Competing Products

20 competing products in Low Back Pain

See all competitors
ProductCompanyStageHype Score
LY3556050 + PlaceboEli LillyPhase 2
52
LY3526318 + PlaceboEli LillyPhase 2
52
DuloxetineShionogiPhase 3
77
Duloxetine + PlaceboShionogiPhase 3
77
Eperisone hydrochloride and Diclofenac sodium + Eperisone hydrochlorideEisaiPhase 3
77
EperisoneEisaiPhase 3
77
Duloxetine + PlaceboEli LillyPhase 3
77
LY3857210 + PlaceboEli LillyPhase 2
52
LY3016859 + PlaceboEli LillyPhase 2
52
Duloxetine + PlaceboEli LillyPhase 3
77
Placebo to Week 16; tanezumab 5mg SC + Placebo to Week 16, tanezumab 10 mg SC + Tanezumab 5 mg SC + Tanezumab 10 mg SC + Tramadol PR oralEli LillyPhase 3
77
Duloxetine + PlaceboEli LillyPhase 3
77
JNJ-42160443 3 mg + JNJ-42160443 1 mg + JNJ-42160443 6 mg/3mg + JNJ-42160443 10 mg + Matching PlaceboJohnson & JohnsonPhase 2
52
tramadol hydrochloride , acetaminophenJohnson & JohnsonApproved
85
tapentadol (CG5503) Immediate Release IR + tapentadol (CG5503) Extended Release (ER) + tapentadol (CG5503) Immediate Release (IR)Johnson & JohnsonPhase 3
77
tapentadol (CG5503) ER + oxycodone CR + placeboJohnson & JohnsonPhase 3
77
ABT-712 + PlaceboAbbViePhase 3
77
ABT-712 + PlaceboAbbViePhase 3
77
hydrocodone/acetaminophen extended release + PlaceboAbbViePhase 2
52
AZD1940 + MidazolamAstraZenecaPhase 1
33

Other Products from Nektar Therapeutics

NKTR-102 + Eribulin + Ixabepilone + Vinorelbine + Gemcitabine + Paclitaxel + Docetaxel + Nab-paclitaxelPhase 3
72
NKTR-181 BID tablets + Placebo to match NKTR-181 BID tabletsPhase 3
72
NKTR-102 + Treatment of Physician's Choice (TPC)Phase 3
72
NKTR-255 at 1.5 ยตg/kg + NKTR-255 at 3.0 ฮผg/kg + NKTR-255 at 3.0/6.0 ฮผg/kgPhase 2/3
60
aerosolized vancomycin or gentamicinPhase 2
47